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In the proceedings of the Third Annual Meeting of the
Association of Cancer Physicians the name of the first
author of the abstract entitled CHLVPP chemotherapy in
advanced Hodgkin's disease was omitted.
The correct version is reproduced below in full:
CHLVPP chemotherapy in advanced Hodgkin's disease
J. McKendrick, J.M.A. Whitehouse, C.J. Williams,
J. Sweetenham, D.H. Jones & G.M. Mead
CRC Medical Oncology Unit, Southampton General
Hospital, Southampton S09 4XY, UK.
From 3/78 until 1/87, 54 patients with Hodgkin's disease
(HD) were treated with chlorambucil 6mgm-2 (max 10mg)
p.o. dl-14; vinblastine 6mgm-2 (max 10mg) i.v. dl and d8.
Procarbazine lOOmgm-2 (max 200mg) p.o. dl-14; and
prednisolone 40mg p.o. dl-14, at monthly intervals and a
mean of 5.7 courses were administered. No patient received
chemotherapy (CT), 12 had relapsed after radiotherapy
(RT). Five patients received combined CT and RT for bulky
mediastinal disease. Forty patients were male and 14 females
(age range 15-73 years, mean 29). Sixteen patients were stage
II, 27 stage III and 11 stage IV. Twenty-nine patients had B
symptoms. Forty-two patients had NSHD, 6 MCHD and 6
LPHD. Mean follow-up time from completion of CT is 42
months (range 10-90). Forty-two (77.8%) patients achieved
CR with 33 (61.1%) in continuous CR at a mean follow-up
of 44 months (range 10-90). Ten patients (18.5%) died
during follow-up, 1 with no clinical evidence of HD 59
months from CT, 1 during CT and 8 from HD. The regime
was generally easy to administer and well tolerated. A mean
of >90% of the planned dose of each drug was adminis-
tered. Five patients required cessation of one of the regime's
drugs and substitution with another agent because of side
effects. Three patients* had mild neuropathy, 2 moderate
nausea, and no patient had alopecia. There were 3 episodes
of neutropaenic fever, one of pneumococcal pneumonia and
one of disseminated HZV. One patient died during CT from
legionella pneumonia. Treatment was delayed in 8 patients
on 10 occasions, 1 due to poor compliance and in 9 due to
neutropaenia.
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